Biomerieux SA
PAR:BIM
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
88.75
110.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Biomerieux SA
Operating Margin
Biomerieux SA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | FR |
| Market Cap | 11.6B EUR |
| Operating Margin |
14%
|
| Country | US |
| Market Cap | 204.9B USD |
| Operating Margin |
17%
|
| Country | US |
| Market Cap | 195.2B USD |
| Operating Margin |
26%
|
| Country | US |
| Market Cap | 146.7B USD |
| Operating Margin |
22%
|
| Country | US |
| Market Cap | 132.6B USD |
| Operating Margin |
18%
|
| Country | IE |
| Market Cap | 110.6B USD |
| Operating Margin |
19%
|
| Country | US |
| Market Cap | 64.7B USD |
| Operating Margin |
14%
|
| Country | DE |
| Market Cap | 55.6B EUR |
| Operating Margin |
12%
|
| Country | CN |
| Market Cap | 319.2B CNY |
| Operating Margin |
37%
|
| Country | US |
| Market Cap | 41.6B USD |
| Operating Margin |
28%
|
| Country | US |
| Market Cap | 37.7B USD |
| Operating Margin |
13%
|
Biomerieux SA
Glance View
Show Overview: BioMérieux SA: Pioneering Diagnostics for a Healthier World BioMérieux SA, a French multinational founded in 1963, stands at the forefront of the global diagnostics industry, driving innovation in infectious disease testing and food safety. With a mission to improve public health through advanced diagnostic solutions, the company has developed a robust portfolio of products that include molecular biology, microbiology, and immunoassays. Its cutting-edge technologies empower healthcare professionals to detect pathogens with speed and accuracy, making a direct impact on patient outcomes and aiding in the prevention of disease outbreaks. By continuously investing in research and development, BioMérieux not only maintains its competitive edge but also expands its reach in emerging markets, balancing its operations with a strong commitment to sustainability and social responsibility. As health crises grow more complex and interconnected, BioMérieux's efforts to enhance diagnostic capacity have never been more critical. The company's recent forays into automation and artificial intelligence signal a shift toward more integrated and efficient testing systems, equipping laboratories and healthcare providers worldwide with the tools necessary to meet rising healthcare demands. Investors can see the potential for substantial returns not only through BioMérieux's innovative product offerings but also through its strategic partnerships and global expansion initiatives. With a solid financial foundation and a vision anchored in improving patient care, BioMérieux represents a compelling opportunity for investors looking to align with a company dedicated to making a meaningful difference in the health of communities across the globe.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Biomerieux SA's most recent financial statements, the company has Operating Margin of 13.7%.
You don't have any saved screeners yet
